Trial intelligence / Profile preview

High Dose Simplified FOLFIRI in Advanced Colorectal Cancer

NCT00286000Phase 2Completed

Sponsor
Ghent University Hospital
Start
Jun 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of FOLFIRI in colorectal cancer (CRC), sponsored by Ghent University Hospital. Started Jun 2004; status: completed.

02

Drugs

FOLFIRI
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT00286000.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00286000.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call